NOVAREX Co.,Ltd. (KOSDAQ:194700)
South Korea · Delayed Price · Currency is KRW 10,230
+160 (1.59%)
At close: Oct 1, 2026
NOVAREX Market Cap
NOVAREX has a market cap or net worth of 175.98 billion as of October 1, 2026. Its market cap has decreased by -51.98% in one year.
Market Cap
175.98B
Enterprise Value
163.73B
Revenue
404.26B
Ranking
n/a
PE Ratio
5.11
Stock Price
10,230.00
ChartMarket Cap Chart
Since November 14, 2018, NOVAREX's market cap has decreased from 180.98B to 175.98B, a decrease of -2.76%. That is a compound annual growth rate of -0.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 175.98B | -28.99% |
| Dec 30, 2025 | 247.83B | 86.67% |
| Dec 30, 2024 | 132.77B | -38.22% |
| Dec 28, 2023 | 214.90B | 19.61% |
| Dec 29, 2022 | 179.68B | -41.23% |
| Dec 30, 2021 | 305.72B | -1.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HEM Pharma | 233.22B |
| DAE HWA Pharmaceutical | 212.96B |
| CellBion | 193.19B |
| HYUNDAI BIOLAND | 170.10B |
| Vivozon Pharmaceutical | 167.56B |
| GC WellBeing | 166.45B |
| Cosmax Nbt | 149.43B |
| Kyung Dong Pharmaceutical | 147.67B |